East Coast Institute for Research Takes on REGN-COV2 Phase 3 Clinical Trial for those Exposed to Someone with COVID-19

East Coast Institute for Research, a clinical investigational site in Jacksonville, Florida, will commence a novel clinical trial next week testing Regeneron’s REGN-COV2, the monoclonal antibody designed to target SARS-COV-2. The study will be led by Dr. Rebecca...